Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
luisa.petraccia@uniroma1.it
Luisa Petraccia
Specializzando
Struttura:
NON ASSEGNATO
E-mail:
luisa.petraccia@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective study
THE LANCET REGIONAL HEALTH. EUROPE
2025
Self-harm by single- and multi-agent medication poisoning in a retrospective analysis of a Poison Control Center database from January 2018 to December 2022
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
2024
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity
JOURNAL OF CLINICAL IMMUNOLOGY
2023
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2
EARD
2022
SARS-CoV-2 was already circulating in Italy, in early December 2019
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
2021
Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis
CLINICAL RHEUMATOLOGY
2021
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis
HEPATOLOGY
2021
Longitudinal evaluation of liver stiffness and outcomes in patients with chronic hepatitis C before and after short- and long-term IFN-free antiviral treatment
CURRENT MEDICAL RESEARCH AND OPINION
2019
Virological and clinical response to interferon-free regimens in patients with HCV-related mixed cryoglobulinemia: Preliminary results of a prospective pilot study
CURRENT DRUG TARGETS
2017
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia
HEPATOLOGY
2016
CIRCULATING MICRORNA IN HEPATOCELLULAR CARCINOMA AS PROGNOSTIC BIOMARKERS
DIGESTIVE AND LIVER DISEASE
2016
Sofosbuvir/Ribavirin in GT2 HCV-Related symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life
...INTERNAL AND EMERGENCY MEDICINE
2016
Sofosbuvir/Ribavirin in GT2 HCV-Related symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life
INTERNAL AND EMERGENCY MEDICINE
2016
Virological and Clinical Response in Patients with HCV-Related Mixed Cryoglobulinemia Treated with Interferon-Free Regimens: Preliminary Results of a Prospective Pilot Study
HEPATOLOGY
2015
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma